Test Market/Actual Use Study Combination Proposed For Switch Candidates
This article was originally published in The Tan Sheet
Executive Summary
Consumer purchasing and use of potential Rx-to-OTC switch drugs may be most accurately predicted by a combination of actual use studies with a form of test marketing, according to Bristol-Myers Squibb Executive Medical Director Carola Friedman, MD